Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in overcoming drug resistance†‡
Abstract
Recently, the importance of targeted covalent
a
Celgene Avilomics Research, 45 Wiggins Avenue, Bedford, MA, USA
E-mail:
jsingh@celgene.com
Fax: +1 781-541-510
Tel: +1 781-541-3700
Recently, the importance of targeted covalent
J. Singh, E. Evans, M. Hagel, M. Labinski, A. Dubrovskiy, M. Nacht, R. C. Petter, A. Prasad, M. Sheets, T. St Martin, R. Tjin Tham Sjin, W. Westlin and Z. Zhu, Med. Chem. Commun., 2012, 3, 780 DOI: 10.1039/C2MD20017A
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content